Skyepharma applies its proprietary oral drug delivery technologies and capabilities to the development of both new chemical entities and differentiated formulations of existing products, in order to provide clinical benefits for patients, to offer additional proprietary protection to innovators, and to support Life Cycle Management.

Skyepharma’s oral drug delivery technologies are used in 10 approved products that are currently sold in numerous different countries by many of the world’s leading pharmaceutical companies.

We also have a number of oral products in various stages of development, some of which are available for licensing.

Skyepharma Oral Drugs

Disclaimer Masterpage